Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
-

-

-
-
-
-

-

 
WKN: A2DR4A / Symbol: ARNA / Name: Arena Pharma / Stock / Biotechnology & Medical Research / Mid Cap /

Arena Pharmaceuticals Inc Stock

For the coming years our community has positive and negative things to say abot the Arena Pharmaceuticals Inc stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Worthwhile Investment for the next years" there were negative voices in the community.

Arena Pharmaceuticals, Inc. (Symbol ARNA) is a biopharmaceutical company based in San Diego, California that focuses on the research, development, and commercialization of novel medications. The company's primary focus is on developing small molecule drugs that target G protein-coupled receptors, which are involved in a wide range of physiological processes. Arena has a diverse pipeline of potential drug candidates in various stages of development, including treatments for pulmonary arterial hypertension, pain, autoimmune diseases, and more. The company's stock is listed on the NASDAQ exchange and is widely considered to be a high-risk/high-reward investment.

Pros and Cons of Arena Pharmaceuticals Inc in the next few years

Pros
?
C******** o* t** e**********
?
S********** s********
?
W********* I********* f** t** n*** y****
Cons
?
G***** c******* t* c**********
?
B****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Arena Pharmaceuticals Inc vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Arena Pharmaceuticals Inc - - - - - - -
Ironwood Pharmaceuticals 0.680% 2.069% -1.333% -23.711% -27.451% -18.681% -
Sage Therapeutics Inc. 0.040% -7.586% -20.370% -70.585% -39.700% -79.833% -
Novocure Ltd 1.490% 25.795% 13.841% -76.180% 1.121% -90.875% -